Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study - Wikidata - awgldk - TriplyDB

Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study

Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study

http://www.wikidata.org/entity/Q34787576

about

Methadone at tapered doses for the management of opioid withdrawal Initial experience of heroin use under a two-chained operant schedule influences drug-seeking behavior after one month of abstinence.Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy?Responses of dopaminergic, serotonergic and noradrenergic networks to acute levo-tetrahydropalmatine administration in naïve rats detected at 9.4 T.Development and validation of a high performance liquid chromatography quantification method of levo-tetrahydropalmatine and its metabolites in plasma and brain tissues: application to a pharmacokinetic study.l-tetrahydropalmatine reduces nicotine self-administration and reinstatement in rats.Simultaneous determination of l-tetrahydropalmatine and its active metabolites in rat plasma by a sensitive ultra-high-performance liquid chromatography with tandem mass spectrometry method and its application in a pharmacokinetic study.Levo-Tetrahydroberberrubine Produces Anxiolytic-Like Effects in Mice through the 5-HT1A Receptor.Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.A computational drug-target network for yuanhu zhitong prescription l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.Levo-tetrahydropalmatine decreases ethanol drinking and antagonizes dopamine D2 receptor-mediated signaling in the mouse dorsal striatum.L-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors.Double target concept for smoking cessation.Paradoxical relationship between RAVE (relative activity versus endocytosis) values of several opioid receptor agonists and their liability to cause dependence.Simultaneous determination of L-tetrahydropalmatine and cocaine in human plasma by simple UPLC-FLD method: application in clinical studies.Pharmacokinetics and Safety Assessment of l-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled Study.Antiaging and Anxiolytic Effects of Combinatory Formulas Based on Four Medicinal Herbs.Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment.Effects of Jitai tablet, a traditional Chinese medicine, on spontaneous withdrawal symptoms and modulation of dopaminergic functions in morphine-dependent rats.Longitudinal changes of dopamine transporters in heroin users during abstinence.Traditional Chinese Medicine (TCM) Therapy.Simultaneous quantification of L-tetrahydropalmatine and its urine metabolites by ultra high performance liquid chromatography with tandem mass spectrometry.Testing of the estrogenic activity and toxicity of Stephania venosa herb in ovariectomized rats.

P2860

Q24200729-01B3E16B-1893-4C86-8A66-62D82E941015 Q33557186-143048B0-F5D2-40E7-B110-6DBD320C8BE2 Q34209414-D9EFEF9E-BCA8-40EF-AE8A-8101130822A3 Q34237450-5CCD04BC-B567-4C59-AD80-17190DAF1FF7 Q36108939-6BED6585-010A-4D71-BF02-44C5488A44AA Q36126120-7CAB4371-18F4-47E0-8C14-1F57A4137D8A Q36183737-51560928-21B8-441D-B8DB-E5286F006C00 Q36199114-D1F09A13-70EA-4A88-B1F4-0431D9408333 Q36249054-B08F04EB-7570-433C-BBC1-71E3CAF4A508 Q36303094-2477022E-4673-43B5-B0B7-AA40A4258795 Q36852570-55C01BDB-27EB-45F8-A700-D3015FA5CED4 Q36879870-1089E9D4-566A-4B90-8279-D3DF1602C2EE Q37426813-2CB5E340-C0A2-4694-A014-CCA00A31BAC0 Q37580642-D1F99C16-F595-47B1-A39D-8B75CB16A196 Q37637054-2ACA5AD8-1943-4ED4-97DB-6477FE9258C1 Q39011217-586EBAAF-CBDE-4FBA-B9EE-010271DBF777 Q39150818-CBAAB317-19F9-4160-9D63-7650C8A4F104 Q39164572-50914236-B842-4D06-BBA0-CC9C1D500BE0 Q39642220-056D4C3A-99D9-4B58-BAFA-236D35300CCB Q42292247-3F3E5906-412F-4AD2-85E5-993D2C229B70 Q44252390-3EECD9E8-157E-47AB-BD59-38C222F0C578 Q47442146-E5709062-401B-4A60-9EFD-0503F0C2F82F Q47681730-5C6C5DF8-0032-4345-B799-A089C6FB48B7 Q47861944-4D5A0B8D-ABC1-48F9-AF41-3F1512667211 Q52303952-E262DED0-D6FB-4220-AE50-A8816D59D64D Q53181171-110416FA-6B8A-45C3-96A6-E5F1826DDEAF

P2860

Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study

http://www.wikidata.org/entity/Q34787576

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Medication of l-tetrahydropalm ...... in heroin users: a pilot study

@ast

Medication of l-tetrahydropalm ...... in heroin users: a pilot study

@en

Medication of l-tetrahydropalm ...... in heroin users: a pilot study

@nl

type

label

Medication of l-tetrahydropalm ...... in heroin users: a pilot study

@ast

Medication of l-tetrahydropalm ...... in heroin users: a pilot study

@en

Medication of l-tetrahydropalm ...... in heroin users: a pilot study

@nl

prefLabel

Medication of l-tetrahydropalm ...... in heroin users: a pilot study

@ast

Medication of l-tetrahydropalm ...... in heroin users: a pilot study

@en

Medication of l-tetrahydropalm ...... in heroin users: a pilot study

@nl

P1433

Q34787576-EB68A6E2-6AD4-444C-8D85-4220240ADDA5

P1476

Q34787576-9E33BA1A-5A20-4854-9227-C844B94FC342

P2093

Q34787576-2C2377C6-0649-4C04-B948-962D2413957F

Q34787576-450ACD8F-ED4D-4432-9B5D-00649D7F42F2

Q34787576-8694A591-B2B2-4BB6-834E-C5284B1ABD68

Q34787576-A3C6A43C-B24C-4A6F-900B-5A9695BE9BCD

Q34787576-ACA8837A-80D0-48CF-9A60-8508291D9331

Q34787576-B29065A9-4D5B-4A95-93C3-9EB7EBD1C9E5

Q34787576-BBDE827F-81DF-4765-BCAF-B5853E91BF15

P2860

Q34787576-05C04906-E61C-4AB9-93C3-04EB5622E884

Q34787576-14A17098-FC4C-4C56-A861-68B76244E678

Q34787576-23CC8756-5B9C-4863-850E-7FFC2CACEAEC

Q34787576-2DEE68B0-2B9A-471A-B82B-91C83F70E002

Q34787576-30449074-1924-4C55-8A30-ADCA008FFAE3

Q34787576-36438AF3-292C-469F-8427-DD423381B065

Q34787576-38B74938-1296-414E-B834-3A995D46DB1D

Q34787576-3C43BE86-8E9E-4D2D-9129-448B4286C933

Q34787576-40157DC0-1724-4D68-8F1F-B0443ECF1C4B

Q34787576-5546150E-E0EB-49B3-AFA3-629432095E7E

P2888

Q34787576-7C3A21E1-1D36-4E11-BFC3-00D23F35E3BF

P304

Q34787576-E8E6688D-E954-4B7E-8E71-B480CEF9C31E

P31

Q34787576-36626152-31AD-4D9E-AA6E-D9A4ABF3DBD2

P356

Q34787576-7E7201B7-8D8A-48FC-B79E-EA37A8457B29

P433

Q34787576-1F3EF982-A5C5-40BC-A8D6-AE0DC482BCE3

P478

Q34787576-892E5000-FCF8-460A-9CBB-0355EAD592B0

P577

Q34787576-0DB6EFAF-0303-4A6F-82FC-58BB8A237C46

P5875

Q34787576-9BFF6296-7C74-43F3-BD26-E007C51596FA

P6179

Q34787576-B9CF3BE8-2090-4DA7-B0BD-29BE34D9BF60

P698

Q34787576-18A8FFE8-1FC8-4A32-A3CF-75A8B2489677

P932

Q34787576-E32AED4C-E465-454E-804C-FEE965BA2A40

P356

J.1745-7254.2008.00817.X

P1433

Acta Pharmacologica Sinica

P1476

Medication of l-tetrahydropalm ...... in heroin users: a pilot study

@en

P2093

Guo-zhang Jin

http://www.w3.org/2001/XMLSchema#string

Jian-lin Qi

http://www.w3.org/2001/XMLSchema#string

Mei-jie Zhang

http://www.w3.org/2001/XMLSchema#string

Shi-jiang Li

http://www.w3.org/2001/XMLSchema#string

Wei Hao

http://www.w3.org/2001/XMLSchema#string

Yong-cong Shao

http://www.w3.org/2001/XMLSchema#string

Zheng Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats

Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats

Dopamine D3 receptor antagonists as therapeutic agents

Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.

Tetrahydropalmatine poisoning: diagnoses of nine adult overdoses based on toxicology screens by HPLC with diode-array detection and gas chromatography-mass spectrometry.

Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.

Anticraving medications for relapse prevention: a possible new class of psychoactive medications.

Neurobiology of addiction: treatment and public policy ramifications.

Role of buprenorphine in the management of heroin addiction.

P2888

j.1745-7254.2008.00817.x

P304

781-788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1745-7254.2008.00817.X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5289889

http://www.w3.org/2001/XMLSchema#string

P6179

1015109528

http://www.w3.org/2001/XMLSchema#string

P698

18565275

http://www.w3.org/2001/XMLSchema#string

P932

4535343

http://www.w3.org/2001/XMLSchema#string